title: A novel distinctive cerebrovascular phenotype is associated with heterozygous Arg179 ACTA2 mutations.
abstract: Mutations in the ACTA2 gene lead to diffuse and diverse vascular diseases; the Arg179His mutation is associated with an early onset severe phenotype due to global smooth muscle dysfunction. Cerebrovascular disease associated with ACTA2 mutations has been likened to moyamoya disease, but appears to have distinctive features. This study involved the analysis of neuroimaging of 13 patients with heterozygous missense mutations in ACTA2 disrupting Arg179. All patients had persistent ductus arteriosus and congenital mydriasis, and variable presentation of pulmonary hypertension, bladder and gastrointestinal problems associated with this mutation. Distinctive cerebrovascular features were dilatation of proximal internal carotid artery, occlusive disease of terminal internal carotid artery, an abnormally straight course of intracranial arteries, and absent basal 'moyamoya' collaterals. Patterns of brain injury supported both large and small vessel disease. Key differences from moyamoya disease were more widespread arteriopathy, the combination of arterial ectasia and stenosis and, importantly, absence of the typical basal 'moyamoya' collaterals. Evaluation of previously published cases suggests some of these features are also seen in the ACTA2 mutations disrupting Arg258. The observation that transition from dilated to normal/stenotic arterial calibre coincides with where the internal carotid artery changes from an elastic to muscular artery supports the hypothesis that abnormal smooth muscle cell proliferation caused by ACTA2 mutations is modulated by arterial wall components. Patients with persistent ductus arteriosus or congenital mydriasis with a label of 'moyamoya' should be re-evaluated to ensure the distinctive neuroimaging features of an ACTA2 mutation have not been overlooked. This diagnosis has prognostic and genetic implications, and mandates surveillance of other organ systems, in particular the aorta, to prevent life-threatening aortic dissection.
authors: Department of Neurology, Great Ormond Street Hospital for Children NHS Trust, London WC1N 3JH, UK.
authors: Pinki
authors: P
authors: Munot
authors: Dawn E
authors: DE
authors: Saunders
authors: Dianna M
authors: DM
authors: Milewicz
authors: Ellen S
authors: ES
authors: Regalado
authors: John R
authors: JR
authors: Ostergaard
authors: Kees P
authors: KP
authors: Braun
authors: Timothy
authors: T
authors: Kerr
authors: Klaske D
authors: KD
authors: Lichtenbelt
authors: Sunny
authors: S
authors: Philip
authors: Christopher
authors: C
authors: Rittey
authors: Thomas S
authors: TS
authors: Jacques
authors: Timothy C
authors: TC
authors: Cox
authors: Vijeya
authors: V
authors: Ganesan
mesh_terms: D000199:Actins / Q000235:genetics*; D000293:Adolescent; D000328:Adult; D001120:Arginine / Q000235:genetics*; D002561:Cerebrovascular Disorders / Q000175:diagnosis / Q000235:genetics; D002648:Child; D002675:Child, Preschool; D005260:Female; D006579:Heterozygote; D006801:Humans; D007223:Infant; D008297:Male; D009072:Moyamoya Disease / Q000175:diagnosis / Q000235:genetics*; D020125:Mutation, Missense / Q000235:genetics*; D010641:Phenotype
chemical_list: C541116:ACTA2 protein, human; D000199:Actins; D001120:Arginine